AAAAAA

   
Results: 1-17 |
Results: 17
Sexual behaviour among youths at high risk for HIV-1 infection in Dar es Salaam, Tanzania
Authors: Mwakagile, D Nimari, E Makwaya, C Mbwana, J Biberfeld, G Mhalu, F Sandstrom, E
Citation: D. Mwakagile et al., Sexual behaviour among youths at high risk for HIV-1 infection in Dar es Salaam, Tanzania, SEX TRANS I, 77(4), 2001, pp. 255-259
Neurological and general outcome in low-risk coronary artery bypass patients using heparin coated circuits
Authors: Svenmarker, S Sandstrom, E Karlsson, T Haggmark, S Jansson, E Appelblad, M Lindholm, R Aberg, T
Citation: S. Svenmarker et al., Neurological and general outcome in low-risk coronary artery bypass patients using heparin coated circuits, EUR J CAR-T, 19(1), 2001, pp. 47-53
Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection
Authors: Hejdeman, B Lenkei, R Leandersson, AC Hultstrom, AL Wahren, B Sandstrom, E Bratt, G
Citation: B. Hejdeman et al., Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection, AIDS RES H, 17(4), 2001, pp. 277-286
Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1infection
Authors: Koppel, K Bratt, G Eriksson, M Sandstrom, E
Citation: K. Koppel et al., Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1infection, INT J STD A, 11(7), 2000, pp. 451-455
A new specific method for measuring S-100B in serum
Authors: Stigbrand, T Nyberg, L Ullen, A Haglid, K Sandstrom, E Brundell, J
Citation: T. Stigbrand et al., A new specific method for measuring S-100B in serum, INT J B MAR, 15(1), 2000, pp. 33-40
The health-related quality of life in a Swedish sample of HIV-infected persons
Authors: Eriksson, LE Nordstrom, G Berglund, T Sandstrom, E
Citation: Le. Eriksson et al., The health-related quality of life in a Swedish sample of HIV-infected persons, J ADV NURS, 32(5), 2000, pp. 1213-1223
AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients
Authors: Gartland, M Gerstoft, J Goebel, F Clumeck, N Cooper, DA Gatell, J Gazzard, B Gerstoft, J Goebel, F Lange, J Montaner, J Reiss, P Rozenbaum, W Vella, S Beveridge, A Cooper, DA Duncombe, C Gold, J Haberl, M Clumeck, N Luyts, D Montaner, J Rachlis, A Marina, R Gerstoft, J Wandall, JH Elbrond, B Molina, JM Pialloux, G Rozenbaum, W Beauvais, L Goebel, FD Staszewski, S Bruns, I Hug, M Reiss, P Lange, J Frissen, PHJ van der Ende, ME Bosboom, M Baas, C Milazzo, F Moroni, M Panebianco, R Clotet, B Artigas, JMG Gonzalez-Lahoz, J Leal, M Rodriguez-Lopo, C Gandarias, B Gazzard, B Johnson, M McKinley, S Page, V Watkins, K Sandstrom, E Belsey, E Darbyshire, J Chodakewitz, J Isaacs, R Jonas, L Meibohm, A Coughlan, M Fiddian, P Gartland, M Harrigan, R Larder, B Maguire, M Millard, J Moore, S Patel, K Shortino, D Tisdale, M Vafidis, I Yeo, J
Citation: M. Gartland et al., AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients, AIDS, 14(4), 2000, pp. 367-374
The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: a potential population for HIV vaccine trials
Authors: Bakari, M Lyamuya, E Mugusi, F Aris, E Chale, S Magao, P Jossiah, R Janabi, M Swai, A Pallangyo, N Sandstrom, E Mhalu, F Biberfeld, G Pallangyo, K
Citation: M. Bakari et al., The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: a potential population for HIV vaccine trials, AIDS, 14(3), 2000, pp. 313-320
Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1
Authors: Leandersson, AC Gilljam, G Fredriksson, M Hinkula, J Alaeus, A Lidman, K Albert, J Bratt, G Sandstrom, E Wahren, B
Citation: Ac. Leandersson et al., Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1, J VIROLOGY, 74(10), 2000, pp. 4888-4890
Isoniazid prophylaxis for tuberculosis prevention among HIV infected police officers in Dar es Salaam
Authors: Bakari, M Moshi, A Aris, EA Chale, S Josiah, R Magao, P Pallangyo, N Mugusi, F Sandstrom, E Biberfeld, G Mhalu, F Pallangyo, K
Citation: M. Bakari et al., Isoniazid prophylaxis for tuberculosis prevention among HIV infected police officers in Dar es Salaam, E AFR MED J, 77(9), 2000, pp. 494-497
Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment
Authors: Bratt, G Eriksson, LE Sandstrom, E Gilljam, G Hinkula, J Albert, J Redfield, R Wahren, B
Citation: G. Bratt et al., Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment, INT J STD A, 10(8), 1999, pp. 514-521
Enantiomeric separation of verapamil and norverapamil using Chiral-AGP (R)as the stationary phase
Authors: Sandstrom, E Lennernas, H Ohlen, K Karlsson, A
Citation: E. Sandstrom et al., Enantiomeric separation of verapamil and norverapamil using Chiral-AGP (R)as the stationary phase, J PHARM B, 21(1), 1999, pp. 43-49
Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence
Authors: Abrams, D Allan, D Antunes, F Breckenridge, A Bruun, J Cameron, W Carbon, C Chalmers, I Chang, H Chodakewitz, J Clendenin, N Clumeck, N Collier, A Collins, G Cooper, E Cooper, D Danner, S D'Aquila, R DeGruttola, V DeMasi, R Dee, L Deyton, L Dixon, D Farthing, C Feinberg, J Fischl, M Flepp, M Gartland, M Gatell, J Gazzard, B Goebel, F Gotzsche, P Gringeri, A Hall, D Hamilton, J Hammer, S Hartigan, P Heath-Chiozzi, M Henry, K Hill, A Hirschel, B Ioannidis, J Kahn, J Katlama, C Katzenstein, D Killen, J King, E de Loes, SK Kravcik, S Lange, J Leavitt, R Leonard, J Maeland, A Mannucci, P Mathiesen, L McDade, H Meibohn, A Melander, H Merigan, T Mulder, J Myers, M Neaton, J Nessling, M Perrin, L Pettinelli, C Phair, J Phillips, A Pinching, A Poppa, A Power, L Reiss, P Richman, D Rooney, J Rousseau, F Rutherford, G Salgo, M Sandstrom, E Saravolatz, L Savidge, G Schnittman, S Schooley, R Seligmann, M Simberkoff, M Skowron, G Slade, P Smith, D Smith, RP Soriano, V Stanley, K Stingl, G Stoffels, P Struthers, L Tierney, C Thompson, M Van der Broeck, R Van Leeuven, R Van Weverling, G Veenstra, J Vella, S Volberding, P Weber, J Winslow, D Yeni, P Yeo, J Dormont, J Sande, M Weller, I Babiker, A Collins, R Darbyshire, J Duncan, W Foulkes, M Hughes, M Peto, R Peto, T Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025
Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial
Authors: Sandstrom, E Wahren, B
Citation: E. Sandstrom et B. Wahren, Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial, LANCET, 353(9166), 1999, pp. 1735-1742
C-reactive protein levels in HIV complicated by opportunistic infections and infections with common bacterial pathogens
Authors: Grutzmeier, S Sandstrom, E
Citation: S. Grutzmeier et E. Sandstrom, C-reactive protein levels in HIV complicated by opportunistic infections and infections with common bacterial pathogens, SC J IN DIS, 31(3), 1999, pp. 229-234
Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment
Authors: Calarota, SA Leandersson, AC Bratt, G Hinkula, J Klinman, DM Weinhold, KJ Sandstrom, E Wahren, B
Citation: Sa. Calarota et al., Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment, J IMMUNOL, 163(4), 1999, pp. 2330-2338
Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents inDar es salaam
Authors: Mbwana, J Mhalu, F Mwakagile, D Masesa, J Moshiro, C Sandstrom, E
Citation: J. Mbwana et al., Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents inDar es salaam, E AFR MED J, 76(6), 1999, pp. 330-334
Risultati: 1-17 |